Key result
ADAR2 suppresses HIF1α to limit IL-10 production in Th17 cells independent of RNA editing.
Why the study?
While ADAR1 plays a critical role in preventing immune activation, ADAR2 exhibits tissue-specific and inducible expression patterns, and its function in the immune system was unknown.
ADAR2 and its upstream regulator DDX5 are critical regulators of Th17 cell effector function, highlighting a potential therapeutic target for intestinal inflammation.
Hypothesis-generating for ADAR2 regulation in T cells; leaves open any role in immunity or cardiovascular disease.
SUMMARY ADAR1 and ADAR2 catalyze adenosine-to-inosine (A-to-I) editing, the most common post-transcriptional modification in RNA. While ADAR1 is ubiquitously expressed and plays a critical role in preventing activation of the host immune system, ADAR2 exhibits tissue-specific and inducible expression patterns, and its function in the immune system is not known. Here, we identify an intragenic super-enhancer involved in the dramatic induction of ADAR2 when naïve helper T cells differentiate toward the Th17 lineage. By editing the inverted repeat sequences at the 3’ untranslated region (UTR) of Malt1 , which encodes a component of the NF-κB activation complex, ADAR2 promotes MALT1 expression and Th17 effector function. Interference with the ADAR2-MALT1 pathway dampens the production of Th17 cytokines and promotes T cell-mediated colitis. This study expands our understanding of RNA editing in adaptive immunity and identifies the ADAR2-MALT1-IL-17A axis as a potential therapeutic target for inflammatory conditions in the intestine.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2020) studied Intestine inflammation. ADAR2 expression and activity vs. Control was evaluated on HIF1α and IL-10 expression in Th17 cells. ADAR2 negatively regulates Hypoxia-Inducible Factor 1-alpha (HIF1α) expression to limit the production of interleukin-10 (IL-10) in Th17 cells in an editing-independent manner.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: